SMTL ID : 6a8g.1 (1 other biounit)

The crystal structure of muPAin-1-IG in complex with muPA-SPD at pH8.5

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.53 Å

Oligo State

hetero-1-1-mer

Ligands

4 x PO4: PHOSPHATE ION(Non-functional Binders)

PO4.1: 2 residues within 4Å: Chain A: Y.5 Chain B: R.221 2 PLIP interactions: 1 interactions with chain A, 1 interactions with chain B Hydrogen bonds: A:Y.5 Salt bridges: B:R.221 PO4.2: 3 residues within 4Å: Chain B: Y.180, K.181, H.237 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:Y.180 Salt bridges: B:K.181, B:H.237 PO4.3: 5 residues within 4Å: Chain B: I.83, L.84, E.86, W.241, H.245 4 PLIP interactions: 4 interactions with chain B Hydrogen bonds: B:E.86, B:W.241, B:W.241 Salt bridges: B:H.245 PO4.4: 5 residues within 4Å: Chain B: R.89, H.96, N.97, N.179, K.181 6 PLIP interactions: 6 interactions with chain B Hydrogen bonds: B:N.97, B:N.97, B:N.179 Salt bridges: B:R.89, B:H.96, B:K.181

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Wang, D. et al., Suppression of Tumor Growth and Metastases by Targeted Intervention in Urokinase Activity with Cyclic Peptides. J.Med.Chem. (2019)

Release Date

2019-02-20

Peptides

muPAin-1-IG: A
Urokinase-type plasminogen activator chain B: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
P

B
A

muPAin-1-IG

Urokinase-type plasminogen activator chain B

Related Entries With Identical Sequence